@article{baudoin:inserm-03121819,
  TITLE = {{Long-term clinical benefits of Sofosbuvir-based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa}},
  AUTHOR = {Baudoin, Mael and Esi Woode, Maame and Nishimwe, Marie Lib{\'e}r{\'e}e and Lemoine, Maud and Sylla, Babacar and Kouanfack, Charles and Moh, Raoul and Seydi, Moussa and Rouveau, Nicolas and Attia, Alain and Lacombe, Karine and Boyer, Sylvie},
  URL = {https://inserm.hal.science/inserm-03121819},
  JOURNAL = {{Liver International}},
  PUBLISHER = {{Wiley-Blackwell}},
  VOLUME = {40},
  NUMBER = {11},
  PAGES = {2643-2654},
  YEAR = {2020},
  MONTH = Nov,
  DOI = {10.1111/liv.14613},
  KEYWORDS = {Africa ; Markov simulation ; direct-acting antivirals (DAAs) ; hepatitis C ; low-income countries},
  PDF = {https://inserm.hal.science/inserm-03121819/file/Manuscript_accepted_version.pdf},
  HAL_ID = {inserm-03121819},
  HAL_VERSION = {v1},
}